ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week

NCT00544180 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped The trial was terminated due to lack of compliance with GCP regulations.

Conditions

Osteoporosis

Interventions

DRUG: Risedronate

Sponsor

Sanofi

Collaborators

[object Object]